Wednesday, July 1, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

UNCY — Unicycive Therapeutics, Inc. SEC Filings | FilingIndex

UNCYNasdaq

Unicycive Therapeutics, Inc.

Pharmaceutical Preparations · DE · CIK 1766140

Developing and commercializing innovative therapies, initially for kidney disease

red 8-K · 90d

+ Watch View on EDGAR ↗

$199M

Market cap

$4.69

Last close

-39.1%

1D

-41.5%

5D

20.1M

Volume

Price · last 40 sessions-41.2%

May 4L $4.69 · H $8.56Jun 30

123

Total filings

Jun 22, 2026

Last filing

12/31

Fiscal year end

All 8-K · 66 10-Q · 15 DEFA14A · 11 SC 13G · 11 10-K · 5 DEF 14A · 5 S-1/A · 5 424B5 · 2

DEFA14ACURRENT REPORTJun 22, 2026 DEFA14ADEFINITIVE ADDITIONAL MATERIALSApr 30, 2026 DEFA14ACURRENT REPORTJun 9, 2025 DEFA14ADEFINITIVE ADDITIONAL MATERIALSMay 22, 2025 DEFA14ACURRENT REPORTMay 21, 2025

Similar companies

Comparable business profile · signals at a glance

AKBAAkebia Therapeutics, Inc.$248.0M+2.7%TVTXTravere Therapeutics, Inc.$4.8B-2.6%ARDXARDELYX, INC.$1.4B-2.5%GPCRStructure Therapeutics Inc.$3.1B+3.8%CTNMContineum Therapeutics, Inc.

DEFA14A

DEFINITIVE ADDITIONAL MATERIALS

May 7, 2025

DEFA14ADEFINITIVE ADDITIONAL MATERIALSMay 8, 2024

DEFA14ADEFINITIVE ADDITIONAL MATERIALSApr 26, 2024

DEFA14ADEFINITIVE ADDITIONAL MATERIALSJun 13, 2023

DEFA14ADEFA14AMay 1, 2023

DEFA14ADEFINITIVE ADDITIONAL MATERIALSApr 20, 2022

$444.2M

+9.3%

PALIPALISADE BIO, INC.$297.2M-6.3%